Understanding patient-reported outcomes in disease states enhances our ability to provide patients with better care and an increased quality of life, said Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP, director of outcomes research, WelldyneRx.
Understanding patient-reported outcomes in disease states enhances our ability to provide patients with better care and an increased quality of life, said Patty Taddei-Allen, PharmD, MBA, BCACP, BCGP, director of outcomes research, WelldyneRx.
Transcript
Are there certain disease states where patient-reported outcomes and real-world evidence are becoming more commonly used?
So, one of the first kind of disease categories where we’re seeing a lot of patient-reported outcomes being obtained in clinical practices, as well as from a managed care perspective, is in oncology patients. We want to see how patients are doing, as far as from their disease state, and are these drugs improving their quality of life, as well as helping with the disease. Other areas where patient-reported outcomes have a lot of potential and are currently being used is in the mental health space, in order to be able to identify when maybe there might need to be a change in therapy if there’s a correlation of a decrease in quality of life.
Also, MS [multiple sclerosis] is another area where we’re using a lot of quality of life outcomes. MS is a disease state that is very highly associated with disability, and by improving quality of life, that’s one of the main goals in treating patients with MS.
How are patient-reported outcomes being obtained?
So, obtaining patient-reported outcomes—there’s a wide spectrum of different types of patient-reported outcomes. There are validated surveys out there. There are some that are disease generic, and so you may use these patient-reported outcomes in different disease states. There are other patient-reported outcomes that are validated that are specific to a disease state. So, it depends on what practice works best in their workflow, or what will work best in the managed care or whatever setting you’re in, to be able to incorporate these different types of patient-reported outcomes to see how patients are responding to their therapy.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
What the Updated Telephone Consumer Protection Act Rules Mean for Health Care Messaging
April 4th 2025As new Federal Communications Commission rules take effect April 11, 2025, mPulse CEO Bob Farrell explains how health organizations can stay compliant while building patient trust through transparency and personalized engagement.
Read More
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More